Stay updated on APL-501 with APL-101 in HCC and RCC Clinical Trial
Sign up to get notified when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.

Latest updates to the APL-501 with APL-101 in HCC and RCC Clinical Trial page
- Check4 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedAn NIH banner announces a transition to using “Super Intelligence” in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the study record remains inaccessible due to a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record page now returns a 403 Forbidden error, replacing the usual content with a minimal error screen. This blocks access to core trial details, and the error page includes a Home button and a revision note.SummaryDifference19%

- Check67 days agoChange DetectedThe page's Revision label was updated from v3.6.5 to v3.6.6, indicating a new software build or patch. This appears to be a backend update rather than a modification to study text or data.SummaryDifference0.1%

Stay in the know with updates to APL-501 with APL-101 in HCC and RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-501 with APL-101 in HCC and RCC Clinical Trial page.